November 14, 2024
Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
First Patient Enrolled in Trial to Evaluate Safety and Feasibility of Innovative Embolic Agent in Expanded Patient Population Utilizing Middle Meningeal Artery Embolization (MMAe)